Pulmonary Arterial Hypertension
Gene: TET2
MODERATE by ClinGen.
TET2 was first reported in relation to autosomal dominant pulmonary arterial hypertension (PAH) in 2020 (Potus et al., PMID: 32192357). Out of a cohort of 2572 cases from the PAH biobank, 6 rare predicted deleterious likely germline variants including missense, nonsense, and frameshift variants were identified in 6 unrelated individuals. The relationship between TET2 and PAH is also supported by experimental evidence including tissue expression in controls and patients, biochemical function as a negative regulator of a proinflammatory response, and knock out TET2 mice exhibiting a PH phenotype.
Sources: Expert listCreated: 8 Aug 2023, 5:31 a.m.
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Phenotypes
Pulmonary arterial hypertension MONDO:0015924, TET2-related
Publications
Gene: tet2 has been classified as Amber List (Moderate Evidence).
Gene: tet2 has been classified as Amber List (Moderate Evidence).
gene: TET2 was added gene: TET2 was added to Pulmonary Arterial Hypertension. Sources: Expert list Mode of inheritance for gene: TET2 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Publications for gene: TET2 were set to 32192357 Phenotypes for gene: TET2 were set to Pulmonary arterial hypertension MONDO:0015924, TET2-related